BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21833756)

  • 21. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Li T; Li D; Cheng L; Wu H; Gao Z; Liu Z; Jiang W; Gao YH; Tian F; Zhao L; Wang S
    Ann Surg Oncol; 2010 Jul; 17(7):1937-44. PubMed ID: 20162464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
    Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
    Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
    Namwat N; Puetkasichonpasutha J; Loilome W; Yongvanit P; Techasen A; Puapairoj A; Sripa B; Tassaneeyakul W; Khuntikeo N; Wongkham S
    J Gastroenterol; 2011 May; 46(5):664-75. PubMed ID: 21076843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
    Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
    Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
    Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
    Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment.
    Yu Y; Liao M; Liu R; Chen J; Feng H; Fu Z
    World J Surg Oncol; 2014 Mar; 12():78. PubMed ID: 24679073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
    Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
    Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scabraside D Extracted from Holothuria scabra Induces Apoptosis and Inhibits Growth of Human Cholangiocarcinoma Xenografts in Mice.
    Assawasuparerk K; Vanichviriyakit R; Chotwiwatthanakun C; Nobsathian S; Rawangchue T; Wittayachumnankul B
    Asian Pac J Cancer Prev; 2016; 17(2):511-7. PubMed ID: 26925636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDAC6 inhibition restores ciliary expression and decreases tumor growth.
    Gradilone SA; Radtke BN; Bogert PS; Huang BQ; Gajdos GB; LaRusso NF
    Cancer Res; 2013 Apr; 73(7):2259-70. PubMed ID: 23370327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic significance of Sox2, CD44 and CD44v6 expression in intrahepatic cholangiocarcinoma.
    Gu MJ; Jang BI
    Pathol Oncol Res; 2014 Jul; 20(3):655-60. PubMed ID: 24482053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells.
    Gentilini A; Lori G; Caligiuri A; Raggi C; Di Maira G; Pastore M; Piombanti B; Lottini T; Arcangeli A; Madiai S; Navari N; Banales JM; Di Matteo S; Alvaro D; Duwe L; Andersen JB; Tubita A; Tusa I; Di Tommaso L; Campani C; Rovida E; Marra F
    Hepatology; 2021 Oct; 74(4):2007-2020. PubMed ID: 33959996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
    Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
    Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WTAP regulates migration and invasion of cholangiocarcinoma cells.
    Jo HJ; Shim HE; Han ME; Kim HJ; Kim KS; Baek S; Choi KU; Hur GY; Oh SO
    J Gastroenterol; 2013 Nov; 48(11):1271-82. PubMed ID: 23354623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
    Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
    Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.